Zein Obagi, M.D., Receives JDD Leaders of Distinction Award

January 20, 2014 - Irvine, California – ZO Skin Health, Inc. is especially pleased to announce that internationally renowned dermatologist Zein Obagi, M.D., is a recipient of the prestigious Journal of Drugs in Dermatology (JDD) Leaders of Distinction Award. Dr. Obagi was nominated by his peers for his excellence in acne treatment and care and thus recognized as a Leader of Distinction in the field of Acne. “I’m honored to be selected as a distinguished leader in acne care by such an esteemed panel of physicians,” says Dr. Obagi. “We commend Dr. Obagi as he earns this well deserved recognition,” said James R. Headley, CEO and President of ZO Skin Health, Inc. “His therapeutic innovations in skin health continue to move the industry forward.” As the Medical Director of ZO Skin Health, Inc., and the Obagi Skin Health Institute, Dr. Obagi has redefined the science of skincare for over 30 years. With his unique approach aimed at achieving and maintaining healthy skin, Dr. Zein Obagi is widely respected as a key innovator in the field of acne prevention. His groundbreaking protocols, products and educational programs have indelibly influenced the skincare industry, allowing for higher success rates and greater patient satisfaction with oil control and acne care. About the JDD The Journal of Drugs in Dermatology (JDD) is a full-color, peer-reviewed publication founded by the renowned Dr. Perry Robins, MD. Now in it's 11th year, it offers one of the fastest routes to disseminate dermatologic information, and is considered the fastest growing publication in dermatology. JDD reaches around 14,500 dermatology healthcare professionals and has been recognized as the official publication of the International Society of Dermatologic Surgery (ISDS) and the Orlando Dermatology Aesthetic and Clinical (ODAC) Conference. To educate physicians, optimize patient outcomes, and disseminate key scientific information.

Objavljeno u: Priopćenja za tisak

Povratak na sve Novosti / U medijima

Prethodna objava:
ZO Skin Health, Inc. Announces Two New Solutions to Address Every Patient’s Skin - ZO® Medical